We are live on ! Find out more
SYNH

Syneos Health, Inc. Class A Common Stock

Delisted

SYNH was delisted on the 27th of September, 2023.

10 hedge funds and large institutions have $9.16M invested in Syneos Health, Inc. Class A Common Stock in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 303 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

97% less funds holding

Funds holding: 31610 (-306)

100% less capital invested

Capital invested by funds: $4.32B → $9.16M (-$4.31B)

100% less funds holding in top 10

Funds holding in top 10: 120 (-12)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 303

Holders
10
Holders Change
-306
Holders Change %
-96.84%
% of All Funds
0.16%
Holding in Top 10
Holding in Top 10 Change
-12
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
2
Reduced
4
Closed
303
Calls
Puts
Net Calls
Net Calls Change

SYNH Hedge Fund Activity: Q3 2023 in Review

10 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Syneos Health, Inc. Class A Common Stock (SYNH) for Q3 2023, worth a combined $9.16M — down 100% from $4.32B a quarter earlier.

Sellers outnumbered buyers: 303 funds closed out of SYNH and 0 opened new positions — a net loss of 303 holders — while 4 trimmed existing stakes and 2 added.

The largest buyer was Skandinaviska Enskilda Banken (SEB), adding an estimated $4.25M. The largest seller was Vanguard Group, exiting entirely with an estimated $433M sold.

  • 10 institutional investors held Syneos Health, Inc. Class A Common Stock (SYNH) as of Q3 2023, down from 316 in Q2 2023.
  • Funds reported $9.16M of Syneos Health, Inc. Class A Common Stock stock for Q3 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Syneos Health, Inc. Class A Common Stock positions in Q3 2023 and 303 closed out, a net change of -303 holders.
  • The largest Syneos Health, Inc. Class A Common Stock buyer in Q3 2023 was Skandinaviska Enskilda Banken (SEB), an estimated $4.25M added.
  • The largest Syneos Health, Inc. Class A Common Stock seller in Q3 2023 was Vanguard Group, an estimated $433M sold.

Based on aggregated 13F filings for Q3 2023.